Inspire Medical Systems logo
Inspire Medical Systems INSP
$ 50.21 0.38%
report update icon

Annual report 2025
added 02-13-2026

Inspire Medical Systems Financial Statements 2025-2011 | INSP

Annual Financial Statements Inspire Medical Systems

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.76 B 5.41 B 5.76 B 7.39 B 6.03 B 5.25 B 1.86 B 752 M - - - - - - -

Shares

29.4 M 29.8 M 29.3 M 28.1 M 27.3 M 26.1 M 23.8 M 14.6 M - - - - - - -

Historical Prices

60 182 197 263 221 202 74.8 53.6 - - - - - - -

Net Income

145 M 53.5 M -21.2 M -44.9 M -42 M -57.2 M -33.2 M -21.8 M -17.5 M -18.5 M -21.3 M - - - -

Revenue

912 M 803 M 625 M 408 M 233 M 115 M 82 M 50.6 M 28.6 M 16.4 M 8.01 M - - - -

Cost of Revenue

133 M 123 M 96.6 M 66.1 M 33.3 M 17.6 M 13.6 M 10.1 M 6.02 M 3.9 M - - - - -

Gross Profit

779 M 680 M 528 M 342 M 200 M 97.8 M 68.4 M 40.5 M 22.5 M 12.5 M 5.2 M - - - -

Operating Income

51 M 36.1 M -40.3 M -47.6 M -39.8 M -56.2 M -34.9 M -20.4 M -16 M -17.3 M - - - - -

Interest Expense

-2.66 M -855 K -195 K -49 K 2.13 M 2.12 M 2.12 M 3.3 M 1.75 M 1.3 M - - - - -

EBITDA

64.9 M 42.6 M -37.4 M -45.7 M -38.6 M -55.4 M -34.4 M -20 M -15.7 M -17.2 M -19.7 M - - - -

Operating Expenses

- - - - 240 M 154 M 103 M 60.9 M 38.6 M 29.8 M 25 M - - - -

General and Administrative Expenses

625 M 530 M 452 M 321 M 203 M 128 M 90.5 M 53.5 M 3.81 M - 2.63 M - - - -

All numbers in USD currency

Quarterly Income Statement Inspire Medical Systems

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

29.3 M 29.5 M 29.7 M 29.7 M 29.9 M 29.7 M 29.6 M 29.6 M 29.4 M 29.2 M 29.1 M 29 M 28.2 M 27.6 M 27.5 M 27.4 M 27.3 M 27.2 M 27.1 M 27.1 M 26.8 M 26.3 M 24.2 M 24.1 M 23.9 M 23.8 M 23.4 M 23.4 M 21.4 M 13.5 M 1.29 M 1.27 M 1.18 M 1.15 M 1.15 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

9.93 M -3.59 M 2.99 M - 18.5 M 9.79 M -10 M - -8.54 M -12 M -15.4 M - -16.8 M -14.5 M -16.7 M - -10.3 M -13.1 M -16.2 M -7.48 M -10.4 M -23.1 M -16.2 M -9.08 M -8.25 M -7.65 M -8.27 M -4.78 M -4.69 M -5.86 M -6.5 M -4.25 M -4.02 M -4.76 M -4.48 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

225 M 217 M 201 M - 203 M 196 M 164 M - 153 M 151 M 128 M - 109 M 91.4 M 69.4 M - 61.7 M 53 M 40.4 M 46 M 35.8 M 12.2 M 21.3 M 26.9 M 20.9 M 18 M 16.2 M 16.6 M 13.1 M 10.9 M 10 M 9.96 M 7.27 M 6.04 M 5.3 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

31.8 M 34.7 M 30.7 M - 32.4 M 29.8 M 24.8 M - 24.4 M 24.3 M 19.9 M - 19.8 M 14.2 M 10 M - 8.62 M 7.52 M 5.98 M - 5.21 M 1.95 M 3.3 M - 3.46 M 3.09 M 2.85 M - 2.47 M 2.1 M 2.29 M - 1.56 M 1.38 M 1.2 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

193 M 182 M 171 M - 171 M 166 M 139 M - 129 M 127 M 108 M - 89.4 M 77.2 M 59.4 M - 53.1 M 45.4 M 34.4 M 38.8 M 30.6 M 10.2 M 18 M 22.7 M 17.4 M 14.9 M 13.4 M 13.4 M 10.6 M 8.84 M 7.75 M 8.08 M 5.71 M 4.67 M 4.1 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

9.64 M -3.32 M -1.48 M - 14.3 M 5.1 M -15.2 M - -13.5 M -16.6 M -19.5 M - -17.2 M -14 M -16.1 M - -9.8 M -12.5 M -15.7 M - -9.89 M -22.8 M -16.4 M - -8.65 M -8.18 M -8.78 M - -4.65 M -5.64 M -5.2 M - -3.65 M -4.38 M -4.12 M - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-66 K -3.5 M 578 K - 118 K -135 K -60 K - -224 K -61 K 17 K - 656 K 494 K 527 K - 537 K 530 K 523 K - 533 K 526 K 525 K - 529 K 523 K 537 K - 680 K 550 K 1.38 M - 428 K 4 K -1 K - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

13.3 M 84 K 1.56 M - 16.2 M 6.5 M -14.4 M - -12.7 M -15.9 M -18.9 M - -16.7 M -13.6 M -15.7 M - -8.92 M -12.2 M -15.5 M - -9.3 M -22.4 M -16.3 M - -8.31 M -7.97 M -8.67 M - -4.36 M -5.45 M -5.1 M - -3.48 M -4.28 M -4.08 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - 156 M 161 M 154 M - 142 M 143 M 128 M - 107 M 91.2 M 75.4 M - 62.9 M 58 M 50.1 M - 40.5 M 33 M 34.5 M - 26.1 M 23.1 M 22.2 M - 15.2 M 14.5 M 12.9 M - 9.36 M 9.05 M 8.22 M - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

159 M 160 M 144 M - 130 M 132 M 126 M - 113 M 113 M 102 M - 85.6 M 76.7 M 63.6 M - 53.2 M 48.7 M 41.9 M - 33.2 M 27 M 29.1 M - 22.4 M 20.3 M 19.6 M - 13.5 M 12.7 M 11.2 M - 864 K 801 K 887 K - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Inspire Medical Systems INSP
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Inspire Medical Systems plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Myomo Myomo
MYO
$ 1.01 1.0 % $ 42.3 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
InspireMD InspireMD
NSPR
$ 0.65 -3.68 % $ 41.8 M israelIsrael
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 7.38 1.79 % $ 223 M canadaCanada
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.48 -1.14 % $ 148 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 4.4 -2.0 % $ 123 M australiaAustralia
AxoGen AxoGen
AXGN
$ 42.21 2.08 % $ 1.94 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 62.84 -2.33 % $ 9.54 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 31.56 -2.46 % $ 27.4 B britainBritain
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 28.17 -0.11 % $ 644 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.73 2.83 % $ 34.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 19.5 2.58 % $ 1.33 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 11.67 -0.77 % $ 454 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.94 2.47 % $ 423 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 11.19 1.08 % $ 463 M usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Inogen Inogen
INGN
$ 6.45 0.47 % $ 172 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.36 3.08 % $ 22.4 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.82 -1.39 % $ 13.9 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 121.21 20.18 % $ 4.21 B usaUSA
Beyond Air Beyond Air
XAIR
$ 5.28 -2.68 % $ 43.8 B usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.43 -0.6 % $ 60 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 80.14 -1.12 % $ 4.37 B britainBritain
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA